Mier JW - Search Results

1

Melanotropin receptors demonstrated in situ in human melanoma.

Tatro JB, Atkins M, Mier JW, Hardarson S, Wolfe H, Smith T, Entwistle ML, Reichlin S. Tatro JB, et al. Among authors: mier jw. J Clin Invest. 1990 Jun;85(6):1825-32. doi: 10.1172/JCI114642. J Clin Invest. 1990. PMID: 2347915 Free PMC article.

2

Mechanisms of action and toxicity of immunotherapy with cytokines.

Mier JW, Atkins MB. Mier JW, et al. Curr Opin Oncol. 1993 Nov;5(6):1067-72. doi: 10.1097/00001622-199311000-00020. Curr Opin Oncol. 1993. PMID: 8305541 Review.

3

Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55.

Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Tilg H, et al. Among authors: mier jw. Blood. 1994 Jan 1;83(1):113-8. Blood. 1994. PMID: 8274730 Free article. Clinical Trial.

4

Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma.

Panka DJ, Atkins MB, Mier JW. Panka DJ, et al. Among authors: mier jw. Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2371s-2375s. doi: 10.1158/1078-0432.CCR-05-2539. Clin Cancer Res. 2006. PMID: 16609061 Review.

5

Transient thyrotoxicosis and persistent hypothyroidism due to acute autoimmune thyroiditis after interleukin-2 and interferon-alpha therapy for metastatic carcinoma: a case report.

Sauter NP, Atkins MB, Mier JW, Lechan RM. Sauter NP, et al. Among authors: mier jw. Am J Med. 1992 Apr;92(4):441-4. doi: 10.1016/0002-9343(92)90278-j. Am J Med. 1992. PMID: 1558092

6

Interleukin-2 and high-dose cisplatin in patients with metastatic melanoma: a pilot study.

Demchak PA, Mier JW, Robert NJ, O'Brien K, Gould JA, Atkins MB. Demchak PA, et al. Among authors: mier jw. J Clin Oncol. 1991 Oct;9(10):1821-30. doi: 10.1200/JCO.1991.9.10.1821. J Clin Oncol. 1991. PMID: 1655988

7

GSK-3beta inhibition enhances sorafenib-induced apoptosis in melanoma cell lines.

Panka DJ, Cho DC, Atkins MB, Mier JW. Panka DJ, et al. Among authors: mier jw. J Biol Chem. 2008 Jan 11;283(2):726-32. doi: 10.1074/jbc.M705343200. Epub 2007 Nov 8. J Biol Chem. 2008. PMID: 17991738 Free article.

8

Chronic inflammatory arthritis after treatment with high-dose interleukin-2 for malignancy.

Massarotti EM, Liu NY, Mier J, Atkins MB. Massarotti EM, et al. Am J Med. 1992 Jun;92(6):693-7. doi: 10.1016/0002-9343(92)90789-e. Am J Med. 1992. PMID: 1605152

9

Lymphokine-activated killer cell generation and recovery. Comparison of an automated cell processing device and a manual procedure.

Ryan T, Atkins MB, Mier JW, Berkman EM. Ryan T, et al. Among authors: mier jw. Transfusion. 1989 Jul-Aug;29(6):491-5. doi: 10.1046/j.1537-2995.1989.29689318445.x. Transfusion. 1989. PMID: 2787549

10

Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients.

Mier JW, Vachino G, van der Meer JW, Numerof RP, Adams S, Cannon JG, Bernheim HA, Atkins MB, Parkinson DR, Dinarello CA. Mier JW, et al. J Clin Immunol. 1988 Nov;8(6):426-36. doi: 10.1007/BF00916947. J Clin Immunol. 1988. PMID: 3265420

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters